The Global Neurothrombectomy Devices Market Size was USD 730 Million in 2021 and is expected to reach USD 1,227 Million by 2030, increasing at a CAGR of 6.3% from 2022 to 2030, as per the Acumen Research and Consulting
The neurothrombectomy devices market is expected to witness significant growth in the coming years due to the increasing prevalence of stroke and rising demand for minimally invasive procedures. The market is expected to be driven by technological advancements in neurothrombectomy devices, increasing adoption of these devices by healthcare providers, and growing awareness about the benefits of using neurothrombectomy devices.
Neurothrombectomy devices are surgical instruments that are used to remove blood clots (thrombi) from brain arteries. These devices are used to treat acute ischemic stroke, a condition caused by a blood clot that prevents blood flow to the brain. The neurothrombectomy devices market refers to the market for these medical devices, which includes a range of products such as stent retrievers, aspiration devices, and mechanical thrombectomy devices. These devices are used in neurothrombectomy, a minimally invasive procedure that involves removing blood clots from brain veins using a catheter implanted in the blood vessel. The neurothrombectomy devices market is predicted to increase significantly in the future years as the prevalence of stroke rises and demand for less invasive therapies rises.
Neurothrombectomy Devices Market Statistics
Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/2414
Neurothrombectomy Devices Market Trends
Some of the key trends in the neurothrombectomy devices market are the development of advanced devices with higher accuracy and precision, the increased use of stent retrievers, and the use of hybrid treatments that combine pharmacological and mechanical techniques. There is also a growing trend toward developing devices that can be employed in a broader variety of patients, such as those with tiny or distant occlusions and those with acute ischemic stroke caused by major artery occlusions.
Growing Incidence of Stroke Drives the Neurothrombectomy Devices Market
Stroke is a primary cause of mortality and disability globally, and its frequency is rising due to factors such as an aging population, unhealthy lifestyles, and the rising prevalence of illnesses such as diabetes and hypertension. As the population ages and the prevalence of stroke risk factors rise, so will the demand for stroke treatment alternatives, including neurothrombectomy procedures. However, the rising prevalence of stroke is propelling the neurothrombectomy devices market, as the number of individuals suffering from stroke rises, so does the demand for stroke treatment alternatives, including neurothrombectomy treatments. Neurothrombectomy procedures can be an important treatment option for patients suffering from acute ischemic stroke, and the rising prevalence of stroke is driving demand for these procedures as well as the growth of the neurothrombectomy devices market.
Neurothrombectomy Devices Market Segmentation
Acumen Research and Consulting has segmented the global neurothrombectomy devices market by product, and end-use.
Neurothrombectomy Devices Market Regional Overview
Geographically, the global neurothrombectomy devices market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. According to the neurothrombectomy devices industry analysis, Europe is dominating the global market in 2021. Factors such as advances in technology, changes in healthcare policies, and economic developments can all influence market dynamics. Europe has an advanced healthcare infrastructure, with a high density of hospitals and access to cutting-edge medical technologies. This may contribute to the region's widespread use of neurothrombectomy procedures. The high prevalence of stroke in Europe may increase the demand for neurothrombectomy treatments and contribute to the region's market growth. Governments in the European Union may be investing in the research and use of new medical technology, such as neurothrombectomy devices, which could help the market grow.
Neurothrombectomy Devices Market Players
Some of the prominent neurothrombectomy devices market companies are Abbott, Stryker Corporation, Boston Scientific Corporation, Medtronic, Phenox GmbH, Acandis GmbH, Edwards Lifesciences Corporation, Penumbra Inc., and Vesalio. Companies in the neurothrombectomy devices market may employ a variety of strategies to acquire a competitive edge and increase market share, including research and development, partnerships and collaborations, marketing and branding, extending indications for use, and expanding geographically.
Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/2414
Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/2414
Mr. Frank Wilson
Acumen Research and Consulting